RJFSA
UTHR icon

Raymond James Financial Services Advisors’s United Therapeutics UTHR Stock Holding History

Raymond James Financial Services Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.3M Buy
6,429
+5,044
+364% +$1.7M ﹤0.01% 1661
2024
Q2 		$441K Sell
1,385
-242
-15% -$64K ﹤0.01% 2627
2024
Q1 		$374K Sell
1,627
-74
-4% -$16.7K ﹤0.01% 2719
2023
Q4 		$374K Sell
1,701
-644
-27% -$148K ﹤0.01% 2594
2023
Q3 		$530K Buy
2,345
+769
+49% +$177K ﹤0.01% 2294
2023
Q2 		$348K Buy
1,576
+677
+75% +$150K ﹤0.01% 2570
2023
Q1 		$201K Buy
899
+55
+7% +$13.6K ﹤0.01% 2913
2022
Q4 		$235K Sell
844
-2,025
-71% -$511K ﹤0.01% 2757
2022
Q3 		$601K Buy
2,869
+141
+5% +$31.5K ﹤0.01% 2139
2022
Q2 		$643K Buy
+2,728
New +$555K ﹤0.01% 2119
2018
Q2 		– Sell
-1,792
Closed -$201K – 2859
2018
Q1 		$201K Buy
1,792
+261
+17% +$33.2K ﹤0.01% 2256
2017
Q4 		$227K Buy
+1,531
New +$195K ﹤0.01% 2175

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Raymond James Financial Services Advisors's UTHR Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its United Therapeutics (UTHR) stake by 364% in Q3 2024, buying an estimated $1.7M and bringing the position to 6,429 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1661.

Raymond James Financial Services Advisors first reported a position in UTHR in Q4 2017 and has held it in 12 quarters since. 624 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • Raymond James Financial Services Advisors held 6,429 shares of United Therapeutics worth $2.3M as of Q3 2024.
  • Raymond James Financial Services Advisors bought 5,044 United Therapeutics shares in Q3 2024, an estimated $1.7M.
  • United Therapeutics made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1661 holding.
  • Raymond James Financial Services Advisors first reported a position in United Therapeutics in Q4 2017 and has held it in 12 quarters since.
  • 624 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.